[1] Bensinger WI, Buckner CD, Cliff RA, et al. Plasma exchange and plasma modification for the removal of anti-red cell antibodies prior to ABO-incompatible marrow transplant[J]. J Clin Apheresis, 1987,3(3): 174-7. [2] Otsubo S, Tanabe K, Shinmura H, et al. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients[J]. Ther Apher Dial, 2004, 8(4): 299-304. [3] Ito C, Ando Y, Akimoto T, et al. Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis[J]. Nippon Jinzo Gakkai Shi, 2000, 42(5): 374-80. [4] Ohta S, Yokoyama H, Ise T, et al. Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation[J]. Intern Med, 1997, 36(7): 487-91. [5] 孟凡义,孙竞,刘启发,等.ABO血型不合异基因外周血干细胞移植对红系造血重建的影响[J].解放军医学杂志,2002,27(4):357-8. [6] Kobayashi T, Yokoyama I, Morozumi K, et al. Comparative study of the efficacy of removal of anti-ABO and anti-gal antibodies by double filtration plasmapheresis[J].Xenotransplantation, 2000, 7(2): 101-8. [7] 俞香宝,王笑云,黄桂英,等.膜式血浆置换153例次的临床应用分析[J].南京医科大学学报,2001,21(4):333-5. |